Rising cost of EpiPen puts pinch on families

The cost of the EpiPen is surging, putting the pinch on many families. The auto-injector's price has risen by more than 480% since 2009, when pharmacies paid slightly more than $100 for a two-pack. The price has since skyrocketed to more than $600.

The cost of the EpiPen is surging, putting the pinch on many families. The auto-injector's price has risen by more than 480% since 2009, when pharmacies paid slightly more than $100 for a two-pack. The price has since skyrocketed to more than $600. "If they don't have [the EpiPen], it could mean life or death," pharmacist Leon Tarasenko says, adding that the high prices are forcing some families to take risks. "Within the last 2 months, we've had about three patients who had issues with the price of an EpiPen. And ... they did not receive it. They just refused to take it," Tarasenko says. Bloomberg senior medical reporter Robert Langreth says the manufacturer of the device, Mylan, has a virtual monopoly after its main competitor launched a recall last fall. He says the company has remarketed the decades-old device without making any significant changes since acquiring it in 2007. Mylan says the EpiPen's price "has changed over time to better reflect important product features and the value the product provides," saying "we've made a significant investment to support the device over the past years."